CTRI/2013/09/003976Other2 期
OPEN LABEL, NON RANDOMIZED, PLACEBO-CONTROLLED STUDY OF PLATELET RICH PLASMA (PRP) IN ALOPECIA, STRAIE AND ATROPHIC ACNE SCAR. -
Gujarat Cancer Society Medical college hospital and research centre0 个研究点目标入组 20 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- Other
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patients between ages of 18 to 70 years.
- •2.Patients with androgenic alopecia or scaring alopecia who are not taking any other treatment.
- •3.Patients with atrophic scars >1 in no. and not taking any other treatment.
- •4.Patients with straie >1 in no.
- •5.Otherwise healthy patients.
- •6.Non-pregnant, non-lactating women
排除标准
- •1.Patients below age of 18 or above the age of 70 yr.
- •2.Patients who were on oral isotretinoin in last 6 months.
- •3.Patients who underwent any surgical modality of treatment in last 2 month.
- •4.Patients who have history of keloid formation or koebnerization for vitiligo.
- •5.Patients with atrophic scars or striae <2 in no.
- •6.Patients who are on oral immunosuppressive drugs.
- •7.Patients having history of any systemic diseases like- renal disease, liver disease, diabetes, tuberculosis, HIV etc.
研究者
相似试验
已完成
3 期
To see the safety and efficacy of Mulmina D in improving the overall general health, physical, psychological and quality of life, in geriatric volunteers.CTRI/2021/10/037286Jagdale industries pvt Ltd100
招募中
4 期
A RANDOMIZED, CONTROLLED, OPEN-LABEL, SINGLE-CENTER, PARALLEL GROUP STUDY TO ASSESS THE EFFECT OF MIRCERA ON DELAYING DIALYSIS IN ANEMIC PATIENTS WITH STAGE 5 CHRONIC KIDNEY DISEASE NOT ON DIALYSIScardiovascular events,stroke,myocardial infarction,leg amputation,admission by heart failure or angina.TCTR20190718006Department of Nephrology Unit Faculty of Medicine Chulalongkorn University200
尚未招募
3 期
Adjuvant Effect Of Nisha-Amlaki And Mahadadimadi Ghrita With Insulin In Diabetes Type I In Pediatric PopulatioCTRI/2024/04/066012All India Institute of Ayurveda, New Delhi
尚未招募
不适用
EFFECT OF DENOSUMAB IN POST-RENAL TRANSPLANT RECIPIENT WITH OSTEOPOROSIS VS PLACEBO- AN OPEN LABELLED PROSPECTIVE RANDOMIZED CONTROLLED TRIAL.CTRI/2022/09/045397IPGMER AND SSKM HOSPITAL KOLKATA
进行中（未招募）
1 期
A RANDOMIZED, OPEN-LABEL, ACTIVE CONTROLLED, SAFETY AND DESCRIPTIVE EFFICACY STUDY IN PEDIATRIC SUBJECTS REQUIRING ANTICOAGULATION FOR THE TREATMENT OF A VENOUS THROMBOEMBOLIC EVENTMedDRA version: 21.1Level: LLTClassification code 10043565Term: Thromboembolic eventSystem Organ Class: 100000004866Venous ThromboembolismEUCTR2014-002606-20-PTBristol-Myers Squibb International Corporation150